Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term olanzapine augmentation of fluoxetine for poststroke depression
ChiCTR-TRC-11001749Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluoxetine and olanzapine in major depressive disorder (MDD) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Hamilton Depression Rating Scale 24-item score. Started Apr 2010; status: completed.
02
Drugs
fluoxetineolanzapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001749.